Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Markmann

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Nature Medicine|February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedentsAbraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Diabetes Care|May 22, 2016
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe HypoglycemiaBernhard J Hering, William R Clarke, Nancy D Bridges, et al.
Kidney International Reports|April 30, 2025
An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant RejectionRania El Fekih, Kurt Franzen, James Hurley, et al.
Hepatology (Baltimore, Md.)|June 28, 2019
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 PatientsDaniel J Firl, Kazunari Sasaki, Vatche G Agopian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetesJames F Markmann, Michael R Rickels, Thomas L Eggerman, et al.
Transplantation|February 4, 2016
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementStephen T Bartlett, James F Markmann, Paul Johnson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2024
Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppressionJulien Vionnet, Jorge Torres-Yaguana, Rosa Miquel, et al.
Transplantation|April 16, 2016
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell ReplacementJames F Markmann, Stephen T Bartlett, Paul Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 11, 2023
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortiumElizabeth C Verna, Meaghan M Phipps, Karim J Halazun, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Nature Medicine|February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedentsAbraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Diabetes Care|May 22, 2016
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe HypoglycemiaBernhard J Hering, William R Clarke, Nancy D Bridges, et al.
Kidney International Reports|April 30, 2025
An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant RejectionRania El Fekih, Kurt Franzen, James Hurley, et al.
Hepatology (Baltimore, Md.)|June 28, 2019
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 PatientsDaniel J Firl, Kazunari Sasaki, Vatche G Agopian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetesJames F Markmann, Michael R Rickels, Thomas L Eggerman, et al.
Transplantation|February 4, 2016
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementStephen T Bartlett, James F Markmann, Paul Johnson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2024
Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppressionJulien Vionnet, Jorge Torres-Yaguana, Rosa Miquel, et al.
Transplantation|April 16, 2016
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell ReplacementJames F Markmann, Stephen T Bartlett, Paul Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 11, 2023
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortiumElizabeth C Verna, Meaghan M Phipps, Karim J Halazun, et al.
Pageof 27